scispace - formally typeset
S

Susan A. Doyle

Researcher at Duke University

Publications -  12
Citations -  399

Susan A. Doyle is an academic researcher from Duke University. The author has contributed to research in topics: Vaccination & Influenza vaccine. The author has an hindex of 8, co-authored 12 publications receiving 295 citations. Previous affiliations of Susan A. Doyle include Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells

TL;DR: It is found that circulating T follicular helper cells, which provide B cell help, not only respond to influenza vaccination but also form long-lasting memory, which highlights the antigen specificity, lineage relationships, and memory properties of human cTFH responses to vaccination.
Journal ArticleDOI

Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans

TL;DR: It is demonstrated that increased percentages of CD8 T cells from aged individuals express CD57 and KLRG1, along with PD‐1 and other inhibitory receptors, markers of senescence, or exhaustion, respectively, which suggest a prominent role forsenescence and/or terminal differentiation for influenza virus‐specific CD8T cells in elderly subjects.
Journal ArticleDOI

Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood.

TL;DR: Gene expression profiling by Illumina arrays revealed highly significant differences in 1368 probes at baseline between Caucasians and African Americans although samples from both cohorts showed comparable changes in transcriptome following vaccination.
Journal ArticleDOI

The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged

TL;DR: The data do not indicate that timing of vaccination affects immune responsiveness of the aged, but shows that in clinical influenza vaccine trials timing of collection of samples can have a major and potentially misleading influence on study outcome.
Journal ArticleDOI

Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.

TL;DR: Accumulation of pre-existing influenza virus-specific immunity in the form of NAb and cross-reactive T cells to conserved virus proteins over a lifetime of exposure to infection and vaccination may influence vaccine-induced CD4 T cell responses in the aged.